Tel-Chai Nation

More good news regarding the efforts to vaccinate as much of Israel's population as possible:

Israeli research shows that the coronavirus vaccine made by Pfizer not only protects those vaccinated from contracting COVID-19, it also helps to prevent immune people from spreading the disease to others.

The question of whether the vaccine would help prevent those who had received it from still being carriers was a key issue as the inoculations were rolled out across the world.

Clinical research conducted by Israel's largest health fund Clalit showed a significant drop in infections among 200,000 people aged 60 and over two weeks after the first vaccinations were given. Not all of the 200,000 people involved in the research had received the vaccination.

Prof. Ran Balicer, head of innovation at Clalit, says that there is no visible effect on general infection rates for days 5 to 12 after the first dose of the two-stage vaccination is administered.

According to the data, there was a slight fall in morbidity on day 13, but by day 14 there was a 33% drop in the spread of the disease between those who were vaccinated and those who were not.

Yes, that's promising, and a good thing that'll help in the long run. Thank goodness vaccines were developed as speedily as they were.

Labels: communications, Israel